Pfizer Inc :Pfizer And Biontech Receive First U.S. Authorization For Emergency Use Of Covid-19 Vaccine In Adolescents.In A Phase 3 Trial, Vaccine Was 100% Effective And Generally Well Tolerated In Participants Aged 12 To 15 Years.Pfizer - Data Also Submitted To European Medicines Agency (Ema) And Other Global Regulators, With Additional Authorizations Expected In Coming Weeks.
精彩评论